LYDIA KNAPP: Open Payments
NPI 1013456128 · NORWICH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 64 payments from 18 companies in 2025. Trend: 2023 $19 · 2024 $0 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Verona Pharma, Inc. | 3 | $83 |
| Lilly USA, LLC | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Novo Nordisk Inc | 4 | $66 |
| Corcept Therapeutics | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $59 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, Ohtuvayre, REXULTI, MOUNJARO, Korlym, Kerendia.
Industry payments across OH — which companies pay providers there.
